0001562180-17-000234.txt : 20170113 0001562180-17-000234.hdr.sgml : 20170113 20170113155158 ACCESSION NUMBER: 0001562180-17-000234 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170113 FILED AS OF DATE: 20170113 DATE AS OF CHANGE: 20170113 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sage Therapeutics, Inc. CENTRAL INDEX KEY: 0001597553 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-299-8380 MAIL ADDRESS: STREET 1: 215 FIRST STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: IGUCHI KIMI CENTRAL INDEX KEY: 0001304815 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36544 FILM NUMBER: 17527783 MAIL ADDRESS: STREET 1: 100 FOXBOROUGH BOULEVARD STREET 2: SUITE 240 CITY: FOXBOROUGH STATE: MA ZIP: 02035 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2017-01-13 false 0001597553 Sage Therapeutics, Inc. SAGE 0001304815 IGUCHI KIMI C/O SAGE THERAPEUTICS, INC. 215 FIRST STREET CAMBRIDGE MA 02142 false true false false CFO, Secretary and Treasurer Common Stock 2017-01-13 4 S false 10000.00 53.92 D 66498.00 D The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. This transaction was executed in multiple trades at prices ranging from $53.72 USD to $54.33 USD; the price reported above reflects the weighted average sale price. These shares include prior ESPP purchases. /s/ Kimi Iguchi 2017-01-13